Healthy Extracts (HYEX) Income from Continuing Operations (2015 - 2026)
Healthy Extracts (HYEX) posted quarterly Income from Continuing Operations of 515995.0 for Q4 2025, down 165.83% year-over-year from 783876.26 in Q4 2024, and up 22.26% quarter-over-quarter from 663710.0 in Q3 2025.
Healthy Extracts (HYEX) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Healthy Extracts' Income from Continuing Operations history runs 11 years deep, the most recent figure standing at 515995.0 for Q4 2025.
- In Q4 2025, Income from Continuing Operations fell 165.83% year-over-year to 515995.0; the TTM figure through Dec 2025 stood at 1598151.0 (down 115.31% YoY), while the FY2025 annual figure was 1190563.0, down 308.13% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 515995.0, up from 663710.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 23169.0 in Q3 2024, with the low at 1764753.0 in Q2 2023.
- The 5-year median for Income from Continuing Operations is 328946.0 (2023), against an average of 445314.15.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 97.18% in 2024, then plunged 2764.65% in 2025.
- Healthy Extracts' Income from Continuing Operations stood at 662057.0 in 2021, then surged by 70.2% to 197326.0 in 2022, then slumped by 79.74% to 354667.0 in 2023, then surged by 45.27% to 194110.0 in 2024, then slumped by 165.83% to 515995.0 in 2025.
- Business Quant data shows HYEX's Income from Continuing Operations at 515995.0 in Q4 2025, 663710.0 in Q3 2025, and 197917.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | -48,762.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -141,018.00 |
| Dec 31, 2025 | -515,995.00 |
| Sep 30, 2025 | -663,710.00 |
| Jun 30, 2025 | -197,917.00 |
| Mar 31, 2025 | -220,529.00 |
| Dec 31, 2024 | -194,110.00 |
| Sep 30, 2024 | -23,169.00 |
| Jun 30, 2024 | -221,741.00 |
| Mar 31, 2024 | -303,225.00 |
| Dec 31, 2023 | -354,667.00 |
| Sep 30, 2023 | -822,950.00 |
| Jun 30, 2023 | -1.76 Mn |
| Mar 31, 2023 | -411,114.00 |
| Dec 31, 2022 | -197,326.00 |
| Sep 30, 2022 | -286,276.00 |
| Jun 30, 2022 | -793,972.00 |
| Mar 31, 2022 | -45,652.00 |
| Dec 31, 2021 | -662,057.00 |
| Sep 30, 2021 | -385,315.00 |
| Jun 30, 2021 | -254,709.00 |